Article information
Abstract
Introduction
Leptospirosis is a zoonosis of worldwide importance. The disease is endemic in Brazil. This study was conducted to describe the clinical and laboratory presentation of leptospirosis in a metropolitan city of Brazil.
MethodsThis is a retrospective study including 201 consecutive patients with leptospirosis admitted to tertiary hospitals in Fortaleza, Brazil, between 1985 and 2006. All patients had clinical and epidemiological data suggestive of leptospirosis, and positive laboratorial test for leptospirosis (microscopic agglutination test, MAT, higher than 1:800).
ResultsA total of 201 patients were included, with mean age of 38.9 ± 15.7 years; 79.1% were male. The mean length from onset of symptoms to admission was 7 ± 3 days. The main clinical signs and symptoms at admission were fever (96.5%), jaundice (94.5%), myalgia (92.5%), headache (74.6%), vomiting (71.6%) and dehydration (63.5%). Hemorrhagic manifestations were present in 35.8%. Acute kidney injury was found in 87% of the patients. Platelet count was less than 100,000/mm3 in 74.3%. Hematuria was found in 42.9%. Death occurred in 31 cases (15.4%).
ConclusionsLeptospirosis is a globally relevant disease with potential fatal outcome. Signs and symptoms suggestive of leptospirosis must be known by any physician in order to institute early adequate treatment to improve outcome. Early indication and daily hemodialysis seems to be beneficial in this group of patients.
Keywords:
leptospirosis
clinical manifestations
laboratory findings
mortality
Full text is only aviable in PDF
References
[1.]
A.R. Bharti, J.E. Nally, J.N. Ricaldi, et al.
Leptospirosis: a zoonotic disease of global importance.
Lancet Infect Dis, 3 (2003), pp. 757-771
[2.]
P.N. Levett.
Leptospirosis.
Clin Microbiol Rev, 14 (2001), pp. 296-326
[3.]
A.I. Ko, M.G. Reis, C.M. Dourado, W.D. Johnson Jr, L.W. Riley.
Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group.
Lancet, 354 (1999), pp. 820-825
[4.]
L.A. Jackson, A.F. Kaufmann, W.G. Adams, et al.
Outbreak of leptospirosis associated with swimming.
Pediatr Infec Dis J, 12 (1993), pp. 48-54
[5.]
W. Tangkanakul, P. Tharmaphornpil, B. Plikaytis, et al.
Risk factor associated with leptospirosis in northeastern Thailand, 1998.
Am J Trop Med Hyg, 63 (2000), pp. 204-208
[6.]
M. Narita, S. Fujitani, D.A. Haake, D.L. Paterson.
Leptospirosis after recreational exposure to water in the Yaeyama islands, Japan.
Am J Trop Med Hyg, 73 (2005), pp. 652-656
[7.]
A.V. Lomar, D. Diament, J.R. Torres.
Leptospirosis in Latin America.
Infect Dis Clin North Am, 14 (2000), pp. 23-39
[8.]
A.R. Katz, V.E. Andsell, P.V. Effler, C.R. Middleton, D.M. Sasaki.
Leptospirosis in Hawaii, 1974-1998: epidemiologic analysis of 353 laboratory-confirmed cases.
Am J Trop Med Hyg, 66 (2002), pp. 61-70
[9.]
F. Mansour-Ghanaei, A.I.I. Sarshad, M.S. Fallah, A. Pourhabibi, K. Pourhabibi, M. Yousefi-Mashhoor.
Leptospirosis in Guilan, a northern province of Iran: assessment of the clinical presentation of 74 cases.
Med Sci Monit, 11 (2005), pp. 219-223
[10.]
A.J. Gonçalves, J.E. de Carvalho, J.B. Guedes e Silva, R. Rozembaum, A.R. Vieira.
Hemoptysis and the adult respiratory distress syndrome as the causes of death in leptospirosis. Changes in the clinical and anatomicopathological patterns.
Rev Soc Bras Med Trop, 25 (1992), pp. 261-270
[11.]
E. Costa, Y.A. Costa, A.A. Lopes, E. Sacramento, J.C. Bina.
Severe forms of leptospirosis: clinical, demographic and environmental aspects.
Rev Soc Bras Med Trop, 34 (2001), pp. 261-267
[12.]
E. Costa, A.A. Lopes, E. Sacramento, et al.
Penicillin at the late stage of leptospirosis: a randomized controlled trial.
Rev Inst Med Trop Sao Paulo, 45 (2003), pp. 141-145
[13.]
R.C. Abdulkader, A.C. Seguro, P.S. Malheiro, E.A. Burdmann, M. Marcondes.
Peculiar electrolytic and hormonal abnormalities in acute renal failure due to leptospirosis.
Am J Trop Med Hyg, 54 (1996), pp. 1-6
[14.]
J.A. Kellum, R. Bellomo, C. Ronco.
Classification of acute kidney injury using RIFLE: what's the purpose?.
Crit Care Med, 35 (2007), pp. 1983-1984
[15.]
E.F. Daher, D.M. Zanetta, M.B. Cavalcante, R.C. Abdulkader.
Risk factors for death and changing patterns in leptospirosis acute renal failure.
Am J Trop Med Hyg, 61 (1999), pp. 630-634
[16.]
E.F. Daher, D.M. Zanetta, R.C. Abdulkader.
Pattern of renal function recovery after leptospirosis acute renal failure.
Nephron Clin Pract, 98 (2004), pp. 8-14
[17.]
A.R. Katz, V.E. Ansdell, P.V. Effler, C.R. Middleton, D.M. Sasaki.
Assessment of the Clinical presentation and Treatment of 353 Cases of Laboratory-Confirmed Leptospirosis in Hawaii, 1974–1998.
Clin Inf Dis, 33 (2001), pp. 1834-1841
[18.]
A.A. Lopes, E. Costa, Y.A. Costa, J.C. Bina, E. Sacramento.
The association between serum potassium at hospital admission and the case-fatality rate of leptospirosis in men.
Rev Inst Med Trop Sao Paulo, 43 (2001), pp. 217-220
[19.]
S. Jauréguiberry, M. Roussel, G. Brinchault-Rabin, et al.
Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France.
Clin Microbiol Infect, 11 (2005), pp. 391-394
[20.]
L. Andrade, S. Cleto, A.C. Seguro.
Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality.
Clin J Am Soc Nephrol, 2 (2007), pp. 739-744
[21.]
A.C. Nicodemo, M.I.S. Duarte, V.A.E. Alves, C.E.H. Takakura, R.T.M. Santos, E.L. Nicodemo.
Lung lesions in human leptospirosis., Microscopic, immmunohistochemical and ultrastructural features related to thrombocytopenia.
Am J Trop Med Hyg, 56 (1997), pp. 181-187
[22.]
J.F.P. Wagenar, G.A. Goris, M.S. Sakundarno, et al.
What role do coagulation disorders play in the pathogenesis of leptospirosis?.
Trop Med Int Health, 12 (2007), pp. 111-122
[23.]
W. Chierakul, P. Tientadakul, Y. Suputtamongkol, et al.
Activation of the Coagulation Cascade in Patients with Leptospirosis.
Clin Infect Dis, 46 (2008), pp. 254-260
[24.]
L. Andrade, E.F. Daher, A.C. Seguro.
Leptospiral nephropathy.
Semin Nephrol, 28 (2008), pp. 383-394
[25.]
A.C. Seguro, A.V. Lomar, A.S. Rocha.
Acute renal failure of leptospirosis: nonoliguric and hypokalemic forms.
Nephron, 55 (1990), pp. 146-151
[26.]
C.N. Edwards, G.D. Nicholson, C.O. Everard.
Thrombocytopenia in leptospirosis.
Am J Trop Med Hyg, 31 (1982), pp. 827-829
[27.]
S. Tantitanawat, S. Tanjatham.
Prognostic factors associated with severe leptospirosis.
J Med Assoc Thai, 86 (2003), pp. 925-931
[28.]
E.F. Daher, F.H. Oliveira Neto, S.M. Ramirez.
Evaluation of hemostasis disorders and anticardiolipin antibody in patients with severe leptospirosis.
Rev Inst Med Trop Sao Paulo, 44 (2002), pp. 85-90
[29.]
M.L. Chang, C.W. Yang, J.C. Chen, et al.
Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis.
World J Gastroenterol, 11 (2005), pp. 5553-5556
[30.]
S. Esen, M. Sunbul, H. Leblebicioglu, C. Eroglu, D. Turan.
Impact of clinical and laboratory findings on prognosis in leptospirosis.
Swiss Med Wkly, 134 (2004), pp. 347-352
[31.]
S. Faine.
Leptospira and leptospirosis.
2d ed., MediSci, (1999),
[32.]
K.M. O’Neil, L.S. Rickman, A.A. Lazarus.
Pulmonary manifestations of leptospirosis.
Rev Infect Dis, 13 (1991), pp. 705-709
[33.]
E.L. Gouveia, J. Metcalfe, A.L.F. Carvalho, et al.
Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil.
Emerg Infect Dis, 14 (2008), pp. 505-508
[34.]
A. Spichler, D. Athanazio, M. Buzzar, et al.
Using death certificate reports to find severe leptospirosis cases, Brazil.
Emerg Infect Dis, 13 (2007), pp. 1559-1561
[35.]
A.M. Luks, S. Lakshminarayanan, J.V. Hirschmann.
Leptospirosis presenting as diffuse alveolar hemorrhage: case report and literature review.
Chest, 123 (2003), pp. 639-643
[36.]
E. Sacramento, A.A. Lopes, E. Costa, O.L. Passos, Y.A. Costa, E.D. Matos.
Electrocardiographic alterations in patients hospitalized with leptospirosis in the Brazilian city of Salvador.
Arq Bras Cardiol, 78 (2002), pp. 267-270
[37.]
E.F. Daher, D.M. Brunetta, G.B. Silva Junior, R.A. Puster, R.M.S.V. Patrocínio.
Pancreatic involvement in fatal human leptospirosis: clinical and histopathological features.
Rev Inst Med Trop Sao Paulo, 45 (2003), pp. 307-313
[38.]
E. Kaya, A. Dervisoglu, C. Eroglu, C. Polat, M. Sunbul, K. Ozkan.
Acute pancreatitis caused by leptospirosis: report of two cases.
World J Gastroenterol, 11 (2005), pp. 4447-4449
[39.]
V.H. Chong, S.K. Goh.
Leptospirosis presenting as acute acalculous cholecystitis and pancreatitis.
Ann Acad Med Singapore, 36 (2007), pp. 215-216
[40.]
A. Spichler, E. Spichler, M. Moock, J.M. Vinetz, J.A.D. Leake.
Acute pancreatitis in fatal anicteric leptospirosis.
Am J Trop Med Hyg, 76 (2007), pp. 886-887
[41.]
C.W. Yang, M.S. Wu, M.J. Pan.
Leptospirosis renal disease.
Nephrol Dial Transplant, 16 (2001), pp. 73-77
[42.]
R.C. Abdulkader, E.F. Daher, E.D. Camargo, C. Spinosa, M.V. Silva.
Leptospirosis severity may be associated with the intensity of humoral immune response.
Rev Inst Med Trop Sao Paulo, 44 (2002), pp. 79-83
[43.]
B.D. Cetin, O. Harmankaya, H. Hasman, A. Gunduz, M. Oktar, E. Seber.
Acute renal failure: a common manifestation of leptospirosis.
Ren Fail, 26 (2004), pp. 655-661
[45.]
D. Munnich, M. Lakatos.
Treatment of human leptospira infections with semicillin (ampicillin) or with amoxil (amoxycillin).
Chemotherapy, 22 (1976), pp. 372-380
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
